Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2006

01-10-2006 | Case Report

De Novo Hepatocellular Carcinoma Occurring in a Transplanted Liver: Case Report and Review of the Literature

Authors: Anca Croitoru, Thomas D. Schiano, Myron Schwartz, Sasan Roayaie, Ruliang Xu, Arief Suriawinata, M. Isabel Fiel

Published in: Digestive Diseases and Sciences | Issue 10/2006

Login to get access

Excerpt

One of the main indications for liver transplantation in patients with end-stage liver disease is hepatitis C virus (HCV)-induced cirrhosis [1, 2]. Cirrhosis from any cause may give rise to hepatocellular carcinoma (HCC). Recurrence of HCV infection in the liver allograft is almost universal and may lead to graft failure and/or cirrhosis in between 10 and 30% of cases within 5 years [35]. Only two cases have been previously reported in the medical literature in which HCC developed in the liver allograft in the setting of recurrent HCV and cirrhosis [6, 7]. We report an additional case of de novo HCC in a cirrhotic allograft with recurrent hepatitis C. …
Literature
1.
go back to reference Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA (2002) Liver transplantation and hepatitis C. Transpl Int 15:61–72PubMedCrossRef Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA (2002) Liver transplantation and hepatitis C. Transpl Int 15:61–72PubMedCrossRef
2.
3.
go back to reference Texeira R, Papatheodoridis GV, Borroughs AK (2001) Management of recurrent hepatitis C after liver transplantation. J Viral Hepat 8:159–168CrossRef Texeira R, Papatheodoridis GV, Borroughs AK (2001) Management of recurrent hepatitis C after liver transplantation. J Viral Hepat 8:159–168CrossRef
4.
go back to reference Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA (2000) Retransplantation for late graft failure: predictors of mortality. Liver Transpl 6:174–179PubMed Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA (2000) Retransplantation for late graft failure: predictors of mortality. Liver Transpl 6:174–179PubMed
6.
go back to reference Saxena R, Ye MQ, Emre S, Klion F, Nalesnik MA, Thung SN (1999) De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 5:81–82PubMedCrossRef Saxena R, Ye MQ, Emre S, Klion F, Nalesnik MA, Thung SN (1999) De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 5:81–82PubMedCrossRef
7.
go back to reference Levitsky J, Faust TW, Cohen SM, Te HS (2002) Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl 8:572PubMedCrossRef Levitsky J, Faust TW, Cohen SM, Te HS (2002) Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl 8:572PubMedCrossRef
8.
go back to reference Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O’Grady J (2002) Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8:482–487PubMedCrossRef Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O’Grady J (2002) Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8:482–487PubMedCrossRef
9.
go back to reference Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B (2001) De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7:S109–S118PubMedCrossRef Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B (2001) De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7:S109–S118PubMedCrossRef
10.
go back to reference Frezza EE, Fung JJ, van Thiel DH (1997) Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 44:1172–11781PubMed Frezza EE, Fung JJ, van Thiel DH (1997) Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 44:1172–11781PubMed
11.
go back to reference Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL (2001) Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34:84–91PubMedCrossRef Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL (2001) Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34:84–91PubMedCrossRef
12.
go back to reference Everson GT (2002) Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 8:S19–S27PubMedCrossRef Everson GT (2002) Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 8:S19–S27PubMedCrossRef
13.
go back to reference Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maartens G, Williams R (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820PubMedCrossRef Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maartens G, Williams R (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820PubMedCrossRef
14.
go back to reference Sanchez EA, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB (2002) De novo tumors after liver transplantation: A single institutional experience. Liver Transpl 8:285–291PubMedCrossRef Sanchez EA, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB (2002) De novo tumors after liver transplantation: A single institutional experience. Liver Transpl 8:285–291PubMedCrossRef
15.
go back to reference Jimenez C, Rodriguez D, Marques E, Loinaz C, Alonso O, Hernandez-Vallejo G, Marin L, Rodriguez F, Garcia I, Moreno L (2002) De novo tumors after orthotopic liver transplantation. Transpl Proc 34:297–298CrossRef Jimenez C, Rodriguez D, Marques E, Loinaz C, Alonso O, Hernandez-Vallejo G, Marin L, Rodriguez F, Garcia I, Moreno L (2002) De novo tumors after orthotopic liver transplantation. Transpl Proc 34:297–298CrossRef
16.
17.
go back to reference Nissen NN, Martin P (2002) Hepatocellular carcinoma: the high risk patient. J Clin Gastroenterol 35:S79–S85PubMedCrossRef Nissen NN, Martin P (2002) Hepatocellular carcinoma: the high risk patient. J Clin Gastroenterol 35:S79–S85PubMedCrossRef
18.
go back to reference Mithoefer AB, Supran S, Freeman RB (2002) Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 8:939–944PubMedCrossRef Mithoefer AB, Supran S, Freeman RB (2002) Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 8:939–944PubMedCrossRef
Metadata
Title
De Novo Hepatocellular Carcinoma Occurring in a Transplanted Liver: Case Report and Review of the Literature
Authors
Anca Croitoru
Thomas D. Schiano
Myron Schwartz
Sasan Roayaie
Ruliang Xu
Arief Suriawinata
M. Isabel Fiel
Publication date
01-10-2006
Published in
Digestive Diseases and Sciences / Issue 10/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9333-8

Other articles of this Issue 10/2006

Digestive Diseases and Sciences 10/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.